Abiopharma

🔍 Moran James M (Executive)

Company: DOVER Corp (DOV)

Report Date: 2026-03-13

Detailed Transactions and Holdings:

• Sold 27 shares of Common Stock at $204.28 per share (Direct)
  Date: 2026-03-13 | Code: F | equity_swap_involved: 0 | shares_owned_after: 10,537.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 26 shares of Common Stock at $204.28 per share (Direct)
  Date: 2026-03-13 | Code: F | equity_swap_involved: 0 | shares_owned_after: 10,511.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 20 shares of Common Stock at $204.28 per share (Direct)
  Date: 2026-03-13 | Code: F | equity_swap_involved: 0 | shares_owned_after: 10,491.00 | transaction_form_type: 4 | Footnotes: F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-13 | Code: H | nature_of_ownership: 401(k) Plan | shares_owned_after: 941.00

Footnotes:

• F1: Shares withheld for taxes in accordance with the terms of the grant upon partial vesting of restricted stock units granted on February 10, 2023.
• F2: Shares withheld for taxes in accordance with the terms of the grant upon partial vesting of restricted stock units granted on February 8, 2024.
• F3: Shares withheld for taxes in accordance with the terms of the grant upon partial vesting of restricted stock units granted on February 14, 2025.